Pedram Dara participated in a Phase 2 MAPS’ clinical trial of MDMA-assisted psychotherapy for PTSD. A life-changing experience that became a catalyst for his healing journey. Since then, he has shared his story and learnings at various psychedelic conferences, webinars, and workshops. He's been on panels with Rick Doblin, Michael Mithoefer, Anne Wagner, Mathew Johnson, Bill Richards, Ben Sessa, Tijmen Bostoen, and other psychedelic researchers. Having been invited to ICPR 2020: Interdisciplinary Conference on Psychedelic Research led him to join the OPEN Foundation’s team where he currently runs its operations and is one of the conference organisers for ICPR 2022. Pedram is extremely passionate about the potential of psychedelics for mental healthcare, but he is also well aware of its pitfalls. He advocates for research participant safety and wellbeing so that safe, beneficial, and accessible applications of psychedelics can be ethically and responsibly integrated into science, healthcare, and society. At ICPR 2022, he’s organising the world’s first dedicated Participant Perspective Panel at a major psychedelic conference to amplify the voice of research participants and mental health patients.